In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition

Antiviral Research

Volumn 108, Issue 1, 2014, Pages 88-93

  Rodríguez, Aixa ^a   Kleinbeck, Kyle ^a   Mizenina, Olga ^a   Kizima, Larisa ^a   Levendosky, Keith ^a   Jean Pierre, Ninochka ^a   Villegas, Guillermo ^a   Ford, Brian E ^a   Cooney, Michael L ^a   Teleshova, Natalia ^a   Robbiani, Melissa ^a   Herold, Betsy C ^b   Zydowsky, Thomas ^a   Fernández Romero, José A ^a  

^a POPULATION COUNCIL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

HPV; Microbicides; STI

Indexed keywords

CARRAGEENAN; DIVINE 9; UNCLASSIFIED DRUG; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 45; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF QUANTITATION; MOUSE; NONHUMAN; OSMOLALITY; PAPILLOMAVIRUS INFECTION; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SHEAR RATE; SHEAR STRESS; VISCOSITY; ANIMAL; CHEMOPROPHYLAXIS; DISEASE MODEL; DRUG EFFECTS; GENETICS; IC50; INTRAVAGINAL DRUG ADMINISTRATION; METABOLISM; MICROBIAL SENSITIVITY TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POST EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; REPORTER GENE; SPERM; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; CARRAGEENAN; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; GENES, REPORTER; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LUCIFERASES; MICE; MICROBIAL SENSITIVITY TESTS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POST-EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; SEMEN; TREATMENT OUTCOME;

EID: 84903218843     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.05.018     Document Type: Article

References (42)

1. Q. Abdool Karim, S.S. Abdool Karim, J.A. Frohlich, A.C. Grobler, C. Baxter, L.E. Mansoor, A.B. Kharsany, S. Sibeko, K.P. Mlisana, Z. Omar, T.N. Gengiah, S. Maarschalk, N. Arulappan, M. Mlotshwa, L. Morris, and D. Taylor Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
2. E.P. Armstrong Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types J. Manage. Care Pharm. 16 2010 217 230
3. O. Begay, N. Jean-Pierre, C.J. Abraham, A. Chudolij, S. Seidor, A. Rodriguez, B.E. Ford, M. Henderson, D. Katz, T. Zydowsky, M. Robbiani, and J.A. Fernandez-Romero Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro AIDS Res. Hum. Retroviruses 27 2011 1019 1024
4. C.B. Buck, C.D. Thompson, J.N. Roberts, M. Muller, D.R. Lowy, and J.T. Schiller Carrageenan is a potent inhibitor of papillomavirus infection PLoS Pathog. 2 2006 e69
5. C. Celum, and J.M. Baeten Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis Antivir. Ther. 17 2012 1483 1493
6. Code of Federal Regulations Animal Welfare Act and Regulation Animals and Animal Products 2001 U.S Department of Agriculture Beltsville, MD (Chapter 1, subchapter A)
7. F. Crostarosa, M. Aravantinou, O.J. Akpogheneta, E. Jasny, A. Shaw, J. Kenney, M. Piatak, J.D. Lifson, A. Teitelbaum, L. Hu, A. Chudolij, T.M. Zydowsky, J. Blanchard, A. Gettie, and M. Robbiani A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy PLoS ONE 4 2009 e8060
8. L. Cruz, and C. Meyers Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types PLoS ONE 8 2013 e68379
9. C.S. Dezzutti, E.R. Brown, B. Moncla, J. Russo, M. Cost, L. Wang, K. Uranker, R.P. Kunjara Na Ayudhya, K. Pryke, J. Pickett, M.A. Leblanc, and L.C. Rohan Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity PLoS ONE 7 2012 e48328
10. J.A. Fernández-Romero, C.J. Abraham, A. Rodriguez, L. Kizima, N. Jean-Pierre, R. Menon, O. Begay, S. Seidor, B.E. Ford, P.I. Gil, J. Peters, D. Katz, M. Robbiani, and T.M. Zydowsky Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge Antimicrob. Agents Chemother. 56 2012 358 368
11. J.A. Fernández-Romero, M. Thorn, S.G. Turville, K. Titchen, K. Sudol, J. Li, T. Miller, M. Robbiani, R.A. Maguire, R.W. Buckheit Jr., T.L. Hartman, and D.M. Phillips Carrageenan/MIV-150 (PC-815), a combination microbicide Sex Transm. Dis. 34 2007 9 14 (Pubitemid 46041501)
12. E.J. Fuchs, L.A. Lee, M.S. Torbenson, T.L. Parsons, R.P. Bakshi, A.M. Guidos, R.L. Wahl, and C.W. Hendrix Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission J. Infect. Dis. 195 2007 703 710
13. P.M. Gorbach, R.E. Weiss, E. Fuchs, R.A. Jeffries, M. Hezerah, S. Brown, A. Voskanian, E. Robbie, P. Anton, and R.D. Cranston The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk Sex Transm. Dis. 39 2012 59 64
14. R.E. Haaland, T. Chaowanachan, T. Evans-Strickfaden, J.H. van de Wijgert, P.H. Kilmarx, C.A. McLean, and C.E. Hart Carrageenan-based gel retains limited anti-HIV-1 activity 8-24 hours after vaginal application by HIV-infected Thai women enrolled in a phase I safety trial J. Acquir. Immune Defic. Syndr. 61 2012 e71 e73
15. B.C. Herold, P.M. Mesquita, R.P. Madan, and M.J. Keller Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections Am. J. Reprod. Immunol. 65 2011 325 333
16. M.J. Keller, P.M. Mesquita, N.M. Torres, S. Cho, G. Shust, R.P. Madan, H.W. Cohen, J. Petrie, T. Ford, L. Soto-Torres, A.T. Profy, and B.C. Herold Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials PLoS ONE 5 2010 e8781
17. J. Kenney, M. Aravantinou, R. Singer, M. Hsu, A. Rodriguez, L. Kizima, C.J. Abraham, R. Menon, S. Seidor, A. Chudolij, A. Gettie, J. Blanchard, J.D. Lifson, M. Piatak Jr., J.A. Fernandez-Romero, T.M. Zydowsky, and M. Robbiani An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques PLoS ONE 6 2011 e15835
18. J. Kenney, A. Rodriguez, L. Kizima, S. Seidor, R. Menon, N. Jean-Pierre, P. Pugach, K. Levendosky, N. Derby, A. Gettie, J. Blanchard, M. Piatak Jr., J.D. Lifson, G. Paglini, T.M. Zydowsky, M. Robbiani, and J.A. Fernandez Romero A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo Antimicrob. Agents Chemother. 57 2013 4001 4009
19. J. Kenney, R. Singer, N. Derby, M. Aravantinou, C.J. Abraham, R. Menon, S. Seidor, S. Zhang, A. Gettie, J. Blanchard, M. Piatak Jr., J.D. Lifson, J.A. Fernandez-Romero, T.M. Zydowsky, and M. Robbiani A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use AIDS Res. Hum. Retroviruses 28 2012 1476 1484
20. P.H. Kilmarx, K. Blanchard, S. Chaikummao, B.A. Friedland, N. Srivirojana, C. Connolly, P. Witwatwongwana, S. Supawitkul, P.A. Mock, T. Chaowanachan, and J. Tappero A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand Sex Transm. Dis. 35 2008 226 232 (Pubitemid 351619516)
21. P.H. Kilmarx, J.H. van de Wijgert, S. Chaikummao, H.E. Jones, K. Limpakarnjanarat, B.A. Friedland, J.M. Karon, C. Manopaiboon, N. Srivirojana, S. Yanpaisarn, S. Supawitkul, N.L. Young, P.A. Mock, K. Blanchard, and T.D. Mastro Safety and acceptability of the candidate microbicide carraguard in Thai women: findings from a phase II clinical trial J. Acquir. Immune Defic. Syndr. 43 2006 327 334 (Pubitemid 44674014)
22. L. Kizima, A. Rodríguez, J. Kenney, N. Derby, O. Mizenina, R. Menon, S. Seidor, S. Zhang, K. Levendosky, N. Jean-Pierre, P. Pugach, G. Villegas, B.E. Ford, A. Gettie, J. Blanchard, M. Piatak Jr., J.D. Lifson, G. Paglini, N. Teleshova, T.M. Zydowsky, M. Robbiani, and J.A. Fernández Romero A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV PLoS ONE 9 2014 e:94547
23. D.R. Lowy, and J.T. Schiller Reducing HPV-associated cancer globally Cancer Prev. Res. (Phila.) 5 2012 18 23
24. D. Marais, D. Gawarecki, B. Allan, K. Ahmed, L. Altini, N. Cassim, F. Gopolang, M. Hoffman, G. Ramjee, and A.L. Williamson The effectiveness of carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection Antivir. Ther. 16 2011 1219 1226
25. S. Martin, K. Blanchard, C. Manopaiboon, S. Chaikummao, K. Schaffer, B. Friedland, and P.H. Kilmarx Carraguard acceptability among men and women in a couples study in Thailand J. Women Health (Larchmt) 19 2010 1561 1567
26. L.S. Massad, M. Einstein, E. Myers, C.M. Wheeler, N. Wentzensen, and D. Solomon The impact of human papillomavirus vaccination on cervical cancer prevention efforts Gynecol. Oncol. 114 2009 360 364
27. P.M. Mesquita, N. Cheshenko, S.S. Wilson, M. Mhatre, E. Guzman, E. Fakioglu, M.J. Keller, and B.C. Herold Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety J. Infect. Dis. 200 2009 599 608
28. F.M. Muchomba, R.E. Gearing, J.M. Simoni, and N. El-Bassel State of the science of adherence in pre-exposure prophylaxis and microbicide trials J. Acquir. Immune Defic. Syndr. 61 2012 490 498
29. National Research Council Guide for the Care and Use of Laboratory Animals 8th ed. 2010 National Academies Press Washington, DC
30. S. Patel, E. Hazrati, N. Cheshenko, B. Galen, H. Yang, E. Guzman, R. Wang, B.C. Herold, and M.J. Keller Seminal plasma reduces the effectiveness of topical polyanionic microbicides J. Infect. Dis. 196 2007 1394 1402 (Pubitemid 351412013)
31. B.A. Richardson, C. Kelly, G. Ramjee, T. Fleming, B. Makanani, S. Roberts, P. Musara, N. Mkandawire, T. Moench, A. Coletti, L. Soto-Torres, and S.A. Karim Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035 J. Acquir. Immune Defic. Syndr. 63 2013 120 125
32. J.N. Roberts, C.B. Buck, C.D. Thompson, R. Kines, M. Bernardo, P.L. Choyke, D.R. Lowy, and J.T. Schiller Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan Nat. Med. 13 2007 857 861 (Pubitemid 47038188)
33. J.W. Romano, M. Robbiani, G.F. Doncel, and T. Moench Non-specific microbicide product development: then and now Curr. HIV Res. 10 2012 9 18
34. J.T. Schiller, X. Castellsague, and S.M. Garland A review of clinical trials of human papillomavirus prophylactic vaccines Vaccine 30 Suppl. 5 2012 F123 F138
35. T.J. Segarra, E. Fakioglu, N. Cheshenko, S.S. Wilson, P.M. Mesquita, G.F. Doncel, and B.C. Herold Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety PLoS ONE 6 2011 e27675
36. S. Skoler-Karpoff, G. Ramjee, K. Ahmed, L. Altini, M.G. Plagianos, B. Friedland, S. Govender, A. De Kock, N. Cassim, T. Palanee, G. Dozier, R. Maguire, and P. Lahteenmaki Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1977 1987
37. H.S. Soedjak Colorimetric determination of carrageenans and other anionic hydrocolloids with methylene blue Anal. Chem. 66 1994 4514 4518 (Pubitemid 124006117)
38. D. Tien, R.L. Schnaare, F. Kang, G. Cohl, T.J. McCormick, T.R. Moench, G. Doncel, K. Watson, R.W. Buckheit, M.G. Lewis, J. Schwartz, K. Douville, and J.W. Romano In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials AIDS Res. Hum. Retroviruses 21 2005 845 853 (Pubitemid 43150316)
39. S.G. Turville, M. Aravantinou, T. Miller, J. Kenney, A. Teitelbaum, L. Hu, A. Chudolij, T.M. Zydowsky, M. Piatak Jr., J.W. Bess Jr., J.D. Lifson, J. Blanchard, A. Gettie, and M. Robbiani Efficacy of carraguard-based microbicides in vivo despite variable in vitro activity PLoS ONE 3 2008 e3162
40. L. Van Damme, A. Corneli, K. Ahmed, K. Agot, J. Lombaard, S. Kapiga, M. Malahleha, F. Owino, R. Manongi, J. Onyango, L. Temu, M.C. Monedi, P. Mak'Oketch, M. Makanda, I. Reblin, S.E. Makatu, L. Saylor, H. Kiernan, S. Kirkendale, C. Wong, R. Grant, A. Kashuba, K. Nanda, J. Mandala, K. Fransen, J. Deese, T. Crucitti, T.D. Mastro, and D. Taylor Preexposure prophylaxis for HIV infection among African women N. Engl. J. Med. 367 2012 411 422
41. A. van der Straten, L. Van Damme, J.E. Haberer, and D.R. Bangsberg Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention AIDS 26 2012 F13 F19
42. S.J. Whitehead, P.H. Kilmarx, K. Blanchard, C. Manopaiboon, S. Chaikummao, B. Friedland, J. Achalapong, M. Wankrairoj, P. Mock, S. Thanprasertsuk, and J.W. Tappero Acceptability of carraguard vaginal gel use among Thai couples AIDS 20 2006 2141 2148 (Pubitemid 44684704)